NeuroPace NPCE Insider Ownership

NASDAQ NPCE

$13.05 -0.46 (-3.40%)

At close: Oct 21, 2026 · 4:00 PM EDT

Insider Holdings by Owner

9.32Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

13.54%

▼-0.013% pp QoQ

Shares Held by Insiders

4.64Mn

filed for Sep 2026

▼-0.09% QoQ

Shares Outstanding

34.28Mn

34,282,567 shares

Direct Holdings

1.05Mn

Indirect: 3.59Mn

Net Shares Traded (QoQ)

-4.29K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Over the past year, NPCE insiders did not buy or sell the stock on the open market.

Apart from open-market trades, NPCE insiders received 82.78K shares in stock awards and gave up 24.5K shares to cover taxes or exercise prices in the past 12 months.
Business Quant data puts insider holdings in NPCE at 4.64Mn shares across insiders' latest Form 4 filings, down 0.09% from 4.65Mn shares at the end of Q2 2026 and up 1.01% from 4.6Mn shares at the end of Q3 2025.
Direct holdings account for 1.05Mn shares (22.68%) of NPCE's insider total, and indirect holdings through trusts, partnerships and family members for 3.59Mn shares (77.32%).
Business Quant counts 12 insiders with holdings in NeuroPace stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
NeuroPace's top three insider holders by shares held are Orbimed Advisors LLC (10% owner, 3.24Mn shares), Frank M. Fischer (Director, 599.53K shares) and Joseph Lacob (Director, 366.48K shares).
Orbimed Advisors LLC holds 69.74% of the combined insider position in NeuroPace.
Institutional investors held 77.53% of NeuroPace stock at the end of Q2 2026, while the latest Form 4 filings of its insiders account for about 13.54%; other investors, including the public, hold roughly 8.93%.
In the past year, 10 insiders of NeuroPace submitted 38 Form 4 filings reporting trades, awards or other transactions.
This summary of NeuroPace insider activity covers Form 4 filings through September 25, 2026.

Form 4 Holdings

Insiders Holding NPCE

Insiders 15

Shares held 9.32Mn

Of outstanding 27.18%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Partners Ii L.P. Accelmed	TenPercentOwner	4,432,948	0	4,432,948	47.6%	23 Nov, 2022
2	Advisors Llc Orbimed	TenPercentOwner	0	3,238,199	3,238,199	34.8%	16 May, 2025
3	Frank M Fischer	Director	599,534	0	599,534	6.4%	22 Jun, 2026
4	Michael Favet	Chief Executive Officer	407,080	0	407,080	4.4%	22 Feb, 2023
5	Irina Ridley	Chief Legal Officer/Secretary	141,139	0	141,139	1.5%	22 Feb, 2023
6	Joel Becker	Chief Executive Officer	138,000	0	138,000	1.5%	04 Sep, 2026
7	Rebecca Kuhn	Chief Financial Officer	131,613	0	131,613	1.4%	06 Jun, 2025
8	Martha Morrell	Chief Medical Officer	95,603	0	95,603	1.0%	25 Sep, 2026
9	Patrick F. Williams	Chief Financial Officer	67,508	0	67,508	0.7%	21 Sep, 2026
10	Rakhi Kumar	Director	23,039	0	23,039	0.2%	22 Jun, 2026
11	Uri Geiger	Director	18,537	0	18,537	0.2%	22 Jun, 2026
12	Joseph Lacob	Director	14,754	0	14,754	0.2%	24 Mar, 2026
13	Renee Ryan	Director	2,890	0	2,890	0.0%	05 Jun, 2026
14	Lisa Andrade	Director	2,890	0	2,890	0.0%	05 Jun, 2026
15	R Scott Huennekens	Director	2,890	0	2,890	0.0%	05 Jun, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

293 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
24 Sep, 2026	Martha Morrell	Chief Medical Officer	Disposed F	335	$13.97	$4.68K	51,357	Direct
20 Sep, 2026	Patrick F. Williams	Chief Financial Officer	Disposed F	1,162	$14.28	$16.59K	67,508	Direct
03 Sep, 2026	Joel Becker	Chief Executive Officer	Disposed F	1,310	$14.75	$19.32K	138,000	Direct
27 Aug, 2026	Joel Becker	Chief Executive Officer	Disposed F	1,126	$14.13	$15.91K	139,310	Direct
27 Aug, 2026	Martha Morrell	Chief Medical Officer	Disposed F	358	$14.13	$5.06K	51,692	Direct
24 Jun, 2026	Martha Morrell	Chief Medical Officer	Disposed F	335	$16.22	$5.43K	52,050	Direct
19 Jun, 2026	Rakhi Kumar	Director	Acquired A	989	$15.63	$15.46K	23,039	Direct
19 Jun, 2026	Uri Geiger	Director	Acquired A	789	$15.63	$12.33K	18,537	Direct
19 Jun, 2026	Frank M Fischer	Director	Acquired A	1,467	$15.63	$22.93K	599,534	Direct
05 Jun, 2026	Renee Ryan	Director	Acquired A	2,890	$0.00	$0	2,890	Direct
05 Jun, 2026	Uri Geiger	Director	Acquired A	2,890	$0.00	$0	17,748	Direct
05 Jun, 2026	Frank M Fischer	Director	Acquired A	2,890	$0.00	$0	598,067	Direct
05 Jun, 2026	R Scott Huennekens	Director	Acquired A	2,890	$0.00	$0	2,890	Direct
05 Jun, 2026	Rakhi Kumar	Director	Acquired A	2,890	$0.00	$0	22,050	Direct
05 Jun, 2026	Lisa Andrade	Director	Acquired A	2,890	$0.00	$0	2,890	Direct
05 Jun, 2026	Renee Ryan	Director	Acquired A	5,368	$0.00	$0	5,368	Direct
05 Jun, 2026	Frank M Fischer	Director	Acquired A	5,368	$0.00	$0	5,368	Direct
05 Jun, 2026	Rakhi Kumar	Director	Acquired A	5,368	$0.00	$0	5,368	Direct
05 Jun, 2026	R Scott Huennekens	Director	Acquired A	5,368	$0.00	$0	5,368	Direct
05 Jun, 2026	Lisa Andrade	Director	Acquired A	5,368	$0.00	$0	5,368	Direct

Showing 1 to 20 of 293 transactions